Public Sector Pension Investment Board boosted its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 28.3% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 145,664 shares of the company's stock after buying an additional 32,157 shares during the quarter. Public Sector Pension Investment Board owned 0.32% of Azenta worth $5,046,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Deutsche Bank AG grew its stake in shares of Azenta by 28.5% during the 4th quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock valued at $210,000 after acquiring an additional 931 shares during the period. SG Americas Securities LLC grew its stake in shares of Azenta by 90.6% during the 1st quarter. SG Americas Securities LLC now owns 30,972 shares of the company's stock valued at $1,073,000 after acquiring an additional 14,719 shares during the period. Principal Financial Group Inc. grew its stake in shares of Azenta by 2.4% during the 1st quarter. Principal Financial Group Inc. now owns 226,491 shares of the company's stock valued at $7,846,000 after acquiring an additional 5,408 shares during the period. Invesco Ltd. grew its stake in shares of Azenta by 39.3% during the 4th quarter. Invesco Ltd. now owns 218,795 shares of the company's stock valued at $10,940,000 after acquiring an additional 61,678 shares during the period. Finally, Russell Investments Group Ltd. grew its stake in shares of Azenta by 195.3% during the 4th quarter. Russell Investments Group Ltd. now owns 12,904 shares of the company's stock valued at $645,000 after acquiring an additional 8,534 shares during the period. Hedge funds and other institutional investors own 99.08% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the company. Evercore ISI set a $33.00 price target on Azenta and gave the stock an "in-line" rating in a research note on Tuesday, August 5th. Stephens started coverage on Azenta in a report on Tuesday, July 22nd. They set an "equal weight" rating and a $35.00 price objective on the stock. Needham & Company LLC decreased their price objective on Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a report on Wednesday, May 7th. Finally, Raymond James Financial raised Azenta from a "market perform" rating to an "outperform" rating and set a $35.00 price objective on the stock in a report on Wednesday, August 6th. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, Azenta presently has an average rating of "Hold" and an average target price of $35.75.
Get Our Latest Stock Analysis on AZTA
Azenta Trading Up 5.3%
Shares of NASDAQ AZTA traded up $1.58 during mid-day trading on Friday, reaching $31.42. The company had a trading volume of 97,131 shares, compared to its average volume of 764,630. The business's 50-day moving average is $31.30 and its 200-day moving average is $33.00. The stock has a market cap of $1.44 billion, a price-to-earnings ratio of -12.97 and a beta of 1.59. Azenta, Inc. has a 52 week low of $23.91 and a 52 week high of $55.63.
Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.13 by $0.06. The firm had revenue of $143.94 million for the quarter, compared to analyst estimates of $149.64 million. Azenta had a positive return on equity of 1.35% and a negative net margin of 18.45%.The business's revenue for the quarter was up .0% on a year-over-year basis. During the same quarter last year, the firm posted $0.14 earnings per share. As a group, equities research analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current year.
Azenta Company Profile
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Stories

Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.